More and more women are seeking treatment for infertility,1probably in part because they are postponing childbearing untilan age when their ability to conceive is diminished. The numberof office visits to U.S. physicians for infertility servicesrose from 600,000 in 1968 to about 1.6 million in 19842. Andmore women are using medications that stimulate ovulation; thenumber of prescriptions for clomiphene dispensed by U.S. pharmaciesnearly doubled from 1973 to 19913. In 1988 approximately 2 millionwomen reported previous exposure to fertility drugs4.
The increased use of ovulation-stimulating medications has causedconcern about their . . . [Full Text of this Article]
References
Related Letters:
Risk of Ovarian Cancer after Treatment for Infertility
Del Priore G., Robischon K., Phipps W. R., Kurman R., Wallach E. E., Zacur H. A., Shapiro S., Rossing M. A., Daling J. R., Weiss N. S., Cramer D. W., Hartge P., Nasca P. C., Whittemore A. S.
Extract |
Full Text
N Engl J Med 1995;
332:1300-1302, May 11, 1995.
Correspondence
This article has been cited by other articles:
Child, T. J., Phillips, S. J., Abdul-Jalil, A. K., Gulekli, B., Tan, S. L.
(2002). A Comparison of In Vitro Maturation and In Vitro Fertilization for Women With Polycystic Ovaries. Obstet Gynecol
100: 665-670
[Abstract][Full Text]
Paavonen, J.
(2001). Chlamydia trachomatis and cancer. Sex. Transm. Infect.
77: 154-156
[Full Text]
Amsterdam, A., Selvaraj, N.
(1997). Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes. Endocr. Rev.
18: 435-461
[Abstract][Full Text]
Del Priore, G., Robischon, K., Phipps, W. R., Kurman, R., Wallach, E. E., Zacur, H. A., Shapiro, S., Rossing, M. A., Daling, J. R., Weiss, N. S., Cramer, D. W., Hartge, P., Nasca, P. C., Whittemore, A. S.
(1995). Risk of Ovarian Cancer after Treatment for Infertility. NEJM
332: 1300-1302
[Full Text]
(1994). DOES CLOMIPHENE CAUSE OVARIAN CANCER?. JWatch General
1994: 4-4
[Full Text]